Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carbapenemase-Producing Enterobacteriaceae”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Post-approval studies (Phase 4)Looking for participantsNCT05979545
What this trial is testing

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Who this might be right for
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more
National University of Singapore 1,900
Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Not applicableEnrolling By InvitationNCT07818109
What this trial is testing

One Health Determinants of Rectal Colonization by ESBL-Producing Enterobacterales in the Community

Who this might be right for
Antimicrobial Resistance (AMR)ESBLGut Microbiota Dysbiosis+4 more
Hospital Italiano de Buenos Aires 432
Large-scale testing (Phase 3)Ended earlyNCT04876430
What this trial is testing

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream Infection
Hospital de Clinicas de Porto Alegre 13
Not applicableWithdrawnNCT03391674
What this trial is testing

Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization

Who this might be right for
Antibiotic Resistant StrainMicrobial Colonization
Rambam Health Care Campus
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Large-scale testing (Phase 3)Temporarily pausedNCT03802461
What this trial is testing

Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization

Who this might be right for
Infection
Susy Hota 40
Not applicableStudy completedNCT05378217
What this trial is testing

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

Who this might be right for
Bacterial Sensitivity TestsAntimicrobial Drug Resistance
Assistance Publique - Hôpitaux de Paris 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT03494959
What this trial is testing

Pentaglobin in CRE and PA Neutropenic Infections

Who this might be right for
Septic Shock
Gruppo Italiano Trapianto di Midollo Osseo 120
Not applicableUnknownNCT05850871
What this trial is testing

Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Qianfoshan Hospital 427
Not applicableEnded earlyNCT03944369
What this trial is testing

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms

Who this might be right for
Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects
Kaleido Biosciences 3
Not applicableStudy completedNCT03401242
What this trial is testing

Prevalence of ESBL and CPE in French Nursing Homes

Who this might be right for
Enterobacteriaceae Infections
Nantes University Hospital 734
Not applicableStudy completedNCT06419296
What this trial is testing

Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation.

Who this might be right for
Bacteremia
Hospital Italiano de Buenos Aires 265
Not applicableStudy completedNCT02709408
What this trial is testing

European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to Carbapenems

Who this might be right for
Carbapenem Resistant Bacteria Infection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2,515
Not applicableNot Yet RecruitingNCT07676513
What this trial is testing

Genomic and Phenotypic Diversity of Carbapenemase-producing Escherichia Coli Strains Circulating in Southern France

Who this might be right for
Antibiotic ResistanceEnterobacteriaceae InfectionsCarbapenem-Resistant Enterobacteriaceae Infection+1 more
Centre Hospitalier Universitaire de Nīmes 163
Not applicableUnknownNCT04516395
What this trial is testing

Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae

Who this might be right for
Drug ResistanceCarbapenem-Resistant Enterobacteriaceae InfectionSepsis+4 more
Phramongkutklao College of Medicine and Hospital 102
Not applicableUnknownNCT06049771
What this trial is testing

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

Who this might be right for
Carbapenem-resistant Enterobacteriaceae
Phramongkutklao College of Medicine and Hospital 72
Large-scale testing (Phase 3)Study completedNCT04146337
What this trial is testing

Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Rambam Health Care Campus 3
Not applicableStudy completedNCT05200546
What this trial is testing

Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management

Who this might be right for
Multidrug-resistant Bacteria Screening
University Hospital, Grenoble 3,921
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Next Page